Skip to main content
. 2017 Feb 17;66(6):172–176. doi: 10.15585/mmwr.mm6606a4

TABLE 2. Reported signs and symptoms* among investigated cases of suspected Zika virus disease (n = 147) — Haiti, October 12, 2015–September 10, 2016.

Symptom/Reported co-infection Total cases (N = 118)
RT-PCR–confirmed (n = 8)
Adults and children with symptoms of Zika virus disease (n = 85)
Pregnant women (n = 20)
GBS cases (n = 13)
No. (%) No. (%) No. (%) No. (%) No. (%)
Temperature >37.2°C (99.0°F)
89 (75.4)
4 (50.0)
70 (82.4)
10 (50.0)
9 (69.2)
Headache
80 (67.8)
3 (37.5)
64 (75.3)
11 (55.0)
5 (38.5)
Nonpurulent conjunctivitis
59 (50.0)
7 (87.5)
49 (57.6)
8 (40.0)
2 (15.4)
Myalgia
58 (49.2)
3 (37.5)
51 (60.0)
5 (25.0)
2 (15.4)
Rash
51 (43.2)
6 (75.0)
41 (48.2)
9 (45.0)
1 (7.7)
Arthralgia
64 (54.2)
3 (37.5)
56 (65.9)
8 (40.0)
3 (23.1)
Digestive symptoms
28 (23.7)
1 (12.5)
21 (24.7)
5 (25.0)
2 (15.4)
Other 26 (22.0) 2 (25.0) 16 (18.8) 7 (35.0) 0 (0)

Abbreviations: GBS = Guillain-Barré syndrome; RT-PCR = reverse transcription–polymerase chain reaction.

* Excludes the 29 cases of congenital microcephaly and one fetus in the adults and children category.

Tingling (six patients); sore throat (four); itching (three) fatigue (four); edema (two); abdominal pain (two); hypertension (one); chikungunya infection (one); lymphadenopathy (one); and paraplegia (one).